BioLine RX (Israel) Price History
BLRX Stock | ILS 2.00 0.10 4.76% |
If you're considering investing in BioLine Stock, it is important to understand the factors that can impact its price. As of today, the current price of BioLine RX stands at 2.00, as last reported on the 2nd of March, with the highest price reaching 2.20 and the lowest price hitting 2.00 during the day. BioLine RX secures Sharpe Ratio (or Efficiency) of -0.27, which signifies that the company had a -0.27 % return per unit of risk over the last 3 months. BioLine RX exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm BioLine RX's Mean Deviation of 5.6, risk adjusted performance of (0.19), and Standard Deviation of 8.18 to double-check the risk estimate we provide.
BioLine Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
BioLine |
Sharpe Ratio = -0.2712
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | BLRX |
Estimated Market Risk
8.18 actual daily | 72 72% of assets are less volatile |
Expected Return
-2.22 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
-0.27 actual daily | 0 Most of other assets perform better |
Based on monthly moving average BioLine RX is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of BioLine RX by adding BioLine RX to a well-diversified portfolio.
BioLine RX Stock Price History Chart
There are several ways to analyze BioLine Stock price data. The simplest method is using a basic BioLine candlestick price chart, which shows BioLine RX price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest Price | November 20, 2024 | 14.0 |
Lowest Price | February 10, 2025 | 2.0 |
BioLine RX March 2, 2025 Stock Price Synopsis
Various analyses of BioLine RX's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell BioLine Stock. It can be used to describe the percentage change in the price of BioLine RX from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of BioLine Stock.BioLine RX Price Daily Balance Of Power | (0.50) | |
BioLine RX Price Rate Of Daily Change | 0.95 | |
BioLine RX Price Action Indicator | (0.15) |
BioLine RX March 2, 2025 Stock Price Analysis
BioLine Stock Price History Data
The price series of BioLine RX for the period between Mon, Dec 2, 2024 and Sun, Mar 2, 2025 has a statistical range of 6.1 with a coefficient of variation of 46.81. The prices are distributed with arithmetic mean of 4.46. The median price for the last 90 days is 4.1. The company had 1:10 stock split on 7th of June 2015.Open | High | Low | Close | Volume | ||
03/02/2025 | 2.10 | 2.20 | 2.00 | 2.00 | ||
02/27/2025 | 2.10 | 2.20 | 2.00 | 2.00 | 8,052,350 | |
02/26/2025 | 2.20 | 2.20 | 2.10 | 2.10 | 11,734,048 | |
02/25/2025 | 2.10 | 2.30 | 2.10 | 2.20 | 2,624,601 | |
02/24/2025 | 2.20 | 2.30 | 2.10 | 2.10 | 4,777,545 | |
02/20/2025 | 2.40 | 2.40 | 2.30 | 2.30 | 11,772,351 | |
02/19/2025 | 2.40 | 2.50 | 2.40 | 2.40 | 7,649,766 | |
02/18/2025 | 2.60 | 2.60 | 2.20 | 2.20 | 39,947,223 | |
02/17/2025 | 2.30 | 2.70 | 2.30 | 2.60 | 23,555,139 | |
02/13/2025 | 2.10 | 2.20 | 2.00 | 2.10 | 4,955,911 | |
02/12/2025 | 2.10 | 2.10 | 2.00 | 2.00 | 11,988,219 | |
02/11/2025 | 2.00 | 2.10 | 2.00 | 2.00 | 10,898,522 | |
02/10/2025 | 2.10 | 2.10 | 2.00 | 2.00 | 14,044,131 | |
02/06/2025 | 2.10 | 2.20 | 2.10 | 2.10 | 6,125,886 | |
02/05/2025 | 2.10 | 2.20 | 2.00 | 2.20 | 10,711,685 | |
02/04/2025 | 2.10 | 2.20 | 2.00 | 2.10 | 20,196,358 | |
02/03/2025 | 2.30 | 2.30 | 2.20 | 2.20 | 25,512,727 | |
01/30/2025 | 2.80 | 3.00 | 2.40 | 2.40 | 65,346,387 | |
01/29/2025 | 3.30 | 3.50 | 3.10 | 3.20 | 67,338,864 | |
01/28/2025 | 3.50 | 3.70 | 3.50 | 3.60 | 9,157,643 | |
01/27/2025 | 3.60 | 3.70 | 3.50 | 3.50 | 8,775,033 | |
01/23/2025 | 3.70 | 3.80 | 3.60 | 3.70 | 12,682,541 | |
01/22/2025 | 3.80 | 3.90 | 3.50 | 3.50 | 19,111,698 | |
01/21/2025 | 4.00 | 4.10 | 3.60 | 3.70 | 30,063,529 | |
01/20/2025 | 3.80 | 4.00 | 3.80 | 4.00 | 6,585,933 | |
01/16/2025 | 3.80 | 4.70 | 3.60 | 3.80 | 57,312,660 | |
01/15/2025 | 4.20 | 4.40 | 4.00 | 4.10 | 25,507,782 | |
01/14/2025 | 4.60 | 4.80 | 4.40 | 4.40 | 17,799,771 | |
01/13/2025 | 5.20 | 5.30 | 4.50 | 4.50 | 18,555,882 | |
01/09/2025 | 4.70 | 5.00 | 4.70 | 4.80 | 6,624,823 | |
01/08/2025 | 5.10 | 5.30 | 4.60 | 4.80 | 20,497,643 | |
01/07/2025 | 5.20 | 5.50 | 5.00 | 5.00 | 25,480,858 | |
01/06/2025 | 7.60 | 7.90 | 5.00 | 5.30 | 41,521,765 | |
01/02/2025 | 6.80 | 7.10 | 6.70 | 7.10 | 3,361,221 | |
12/31/2024 | 6.40 | 6.70 | 6.30 | 6.40 | 2,631,218 | |
12/30/2024 | 6.50 | 6.90 | 6.30 | 6.40 | 1,732,119 | |
12/26/2024 | 6.70 | 7.00 | 6.60 | 6.80 | 3,221,416 | |
12/25/2024 | 6.70 | 7.00 | 6.60 | 6.70 | 3,266,450 | |
12/24/2024 | 6.60 | 7.00 | 6.50 | 6.90 | 7,419,969 | |
12/23/2024 | 7.00 | 7.20 | 6.40 | 6.70 | 7,190,075 | |
12/19/2024 | 5.30 | 5.90 | 5.30 | 5.70 | 2,761,339 | |
12/18/2024 | 5.80 | 6.00 | 5.60 | 5.80 | 6,565,810 | |
12/17/2024 | 6.30 | 6.50 | 6.10 | 6.30 | 4,175,658 | |
12/16/2024 | 6.70 | 6.90 | 6.30 | 6.50 | 4,389,515 | |
12/12/2024 | 7.00 | 7.20 | 6.80 | 6.90 | 4,362,464 | |
12/11/2024 | 7.20 | 7.60 | 6.90 | 7.00 | 3,807,758 | |
12/10/2024 | 7.20 | 7.50 | 7.00 | 7.10 | 2,249,463 | |
12/09/2024 | 7.60 | 7.90 | 7.20 | 7.50 | 2,916,996 | |
12/05/2024 | 7.70 | 7.90 | 7.60 | 7.60 | 1,931,287 | |
12/04/2024 | 7.90 | 8.10 | 7.60 | 7.70 | 1,500,105 | |
12/03/2024 | 7.70 | 8.20 | 7.70 | 8.10 | 1,952,584 | |
12/02/2024 | 7.80 | 8.20 | 7.70 | 7.70 | 1,375,540 | |
11/28/2024 | 8.40 | 8.50 | 7.80 | 8.10 | 1,955,999 | |
11/27/2024 | 8.30 | 8.30 | 8.00 | 8.10 | 2,620,545 | |
11/26/2024 | 7.80 | 8.30 | 7.80 | 8.00 | 4,418,458 | |
11/25/2024 | 8.90 | 9.80 | 7.20 | 7.80 | 21,980,182 | |
11/21/2024 | 12.60 | 12.70 | 10.00 | 10.50 | 13,837,079 | |
11/20/2024 | 13.30 | 14.20 | 13.30 | 14.00 | 2,775,222 | |
11/19/2024 | 12.40 | 12.70 | 12.10 | 12.70 | 878,106 | |
11/18/2024 | 12.70 | 12.80 | 12.00 | 12.30 | 1,089,353 | |
11/14/2024 | 12.00 | 12.60 | 12.00 | 12.50 | 2,024,749 |
About BioLine RX Stock history
BioLine RX investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for BioLine is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in BioLine RX will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing BioLine RX stock prices may prove useful in developing a viable investing in BioLine RX
BioLineRx Ltd., a clinical stage biopharmaceutical development company, focuses on oncology and immunology. BioLineRx Ltd. was founded in 2003 and is based in Modiin, Israel. BIOLINE RX operates under Biotechnology classification in Israel and is traded on Tel Aviv Stock Exchange. It employs 48 people.
BioLine RX Stock Technical Analysis
BioLine RX technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Balance Of Power Now
Balance Of PowerCheck stock momentum by analyzing Balance Of Power indicator and other technical ratios |
All Next | Launch Module |
BioLine RX Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for BioLine RX's price direction in advance. Along with the technical and fundamental analysis of BioLine Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of BioLine to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | (0.19) | |||
Jensen Alpha | (2.29) | |||
Total Risk Alpha | (1.97) | |||
Treynor Ratio | 0.8448 |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Complementary Tools for BioLine Stock analysis
When running BioLine RX's price analysis, check to measure BioLine RX's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioLine RX is operating at the current time. Most of BioLine RX's value examination focuses on studying past and present price action to predict the probability of BioLine RX's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioLine RX's price. Additionally, you may evaluate how the addition of BioLine RX to your portfolios can decrease your overall portfolio volatility.
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
CEOs Directory Screen CEOs from public companies around the world |